VP, Head of Cell & Genetic Medicines Discovery

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Senior Thought Leader Liaison, Multiple Myeloma

Johnson & Johnson is a leader in healthcare innovation, aiming to prevent, treat, and cure complex diseases. The Senior Thought Leader Liaison for Multiple Myeloma will lead KOL engagement strategies and collaborate with various teams to enhance brand advocacy and educational initiatives.

Senior Thought Leader Liaison, Multiple Myeloma - Northwest

Head of Customer Engagement and Content Excellence

Principal Medical Science Liaison, Oncology, Solid Tumor 

Associate Director, Thought Leader Liaison & Medical Education (Dermatology)

Senior Thought Leader Liaison, Multiple Myeloma East Central

Associate Director, Thought Leader Liaison & Medical Education, Immunology / Dermatology

Sign up with Google

Sign in with Google